Differential Effect of Ticagrelor Versus Prasugrel on Coronary Blood Flow Velocity in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Author(s) -
Dimitrios Alexopoulos,
Αθανάσιος Μούλιας,
Nikolaos Koutsogiannis,
Ioanna Xanthopoulou,
Apostolos T Kakkavas,
Eleni Mavronasiou,
Periklis Davlouros,
George Hahalis
Publication year - 2013
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.113.000293
Subject(s) - ticagrelor , prasugrel , medicine , acute coronary syndrome , clopidogrel , percutaneous coronary intervention , cardiology , loading dose , anesthesia , confidence interval , myocardial infarction
Prasugrel and ticagrelor provide a superior anti-ischemic action than clopidogrel, with some of ticagrelor's benefits possibly attributed to adenosine-mediated mechanisms. We aimed to compare the effect of maintenance dose of ticagrelor versus prasugrel on coronary blood flow velocity (CBFV) during increasing doses of intravenously administered adenosine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom